Dog Cancer Stages: Understanding How Vets Stage Lymphoma and Other Cancers

If your dog has been diagnosed with cancer, one of the first things your veterinarian will determine is the stage. Staging tells you how far the cancer has spread through your dog's body, and it plays a major role in deciding which treatment approach will give your dog the best outcome.

While the staging systems vary depending on the type of cancer, understanding the basics can help you have more informed conversations with your vet and feel more confident about the treatment plan ahead.

‍

What Does Cancer Staging Mean?

Cancer staging is a way of describing the extent of disease in the body at the time of diagnosis. In the simplest terms, it answers the question: How much cancer is there, and where is it?

Staging matters because it directly influences the treatment approach your veterinarian recommends, the expected prognosis and survival time, how aggressively the cancer needs to be treated, and whether surgery, chemotherapy, radiation, or a combination is most appropriate.

A cancer caught at an early stage with limited spread generally has a better prognosis than one that has already reached multiple organs. But staging isn't destiny — many dogs with advanced-stage cancer still respond well to treatment and enjoy a good quality of life.

‍

The General TNM Staging System

For most solid tumors in dogs — such as mast cell tumors, osteosarcoma, and mammary tumors — veterinarians use the TNM system, which stands for Tumor, Node, and Metastasis.

Tumor (T) describes the size and extent of the primary tumor. T1 is typically a small, localized tumor, while T3 or T4 indicates a large tumor or one that has invaded surrounding tissue.

Node (N) indicates whether the cancer has spread to nearby lymph nodes. N0 means no lymph node involvement, while N1 or higher means cancer cells have been found in regional lymph nodes.

Metastasis (M) tells you whether the cancer has spread to distant parts of the body. M0 means no distant spread, while M1 means the cancer has metastasized to other organs like the lungs, liver, or bones.

These three factors are combined to assign an overall stage, typically ranging from Stage I (early, localized disease) to Stage IV (advanced, widespread disease).

‍

How Lymphoma Staging Works Differently

Lymphoma uses its own staging system because it behaves differently from solid tumors. Since lymphoma originates in the lymphatic system — which runs throughout the entire body — it's already a systemic disease by nature. The World Health Organization (WHO) staging system for canine lymphoma uses Stages I through V:

Stage I: Cancer is found in only a single lymph node or lymphoid tissue in a single organ.

Stage II: Multiple lymph nodes are affected, but only on one side of the diaphragm (either all in the chest area or all in the abdomen).

Stage III: Lymph nodes on both sides of the diaphragm are involved — meaning the disease has spread throughout the lymphatic system. This is the most commonly diagnosed stage.

Stage IV: The liver and/or spleen are involved in addition to lymph node disease.

Stage V: The cancer has spread to the bone marrow, blood, or other organs outside the lymphatic system (such as the eyes, skin, or central nervous system).

Each stage also receives a substage classification of A (the dog appears clinically healthy, with no outward symptoms) or B (the dog is showing clinical signs like vomiting, diarrhea, weight loss, or lethargy). Dogs with substage A generally have a better prognosis because their bodies are still coping well with the disease.

You can dive deeper into the different types of canine lymphoma and how type and stage interact to affect your dog's treatment options.

‍

How Your Veterinarian Determines the Stage

Staging isn't just a visual assessment — it requires specific diagnostic tests to get an accurate picture of how far the cancer has spread. For lymphoma, a full staging workup typically includes a physical examination to assess lymph node size in multiple locations, a complete blood count (CBC) and chemistry panel to check organ function, a fine needle aspirate or biopsy of affected lymph nodes, chest X-rays to check for disease in the thorax, an abdominal ultrasound to evaluate the liver, spleen, and abdominal lymph nodes, and a bone marrow aspirate to determine if Stage V disease is present.

Your oncologist may also recommend flow cytometry, which identifies whether the lymphoma is B-cell or T-cell type. This matters because B-cell lymphomas generally respond better to treatment than T-cell variants.

‍

How Stage Affects Treatment and Prognosis

In general, dogs diagnosed at earlier stages with substage A have better outcomes. Here's what the research tells us about prognosis by stage for multicentric lymphoma:

Stages I-II: Relatively rare at diagnosis since lymphoma tends to spread quickly, but dogs caught early can have longer remission times with appropriate treatment.

Stage III-IV, substage A: This is where most dogs are diagnosed. With aggressive chemotherapy (like the CHOP protocol), approximately 80-90% of dogs achieve remission, with median survival times of 12 to 14 months for B-cell lymphoma.

Stage V or substage B: More advanced disease that has spread to the bone marrow or is causing systemic illness. Prognosis is less favorable, but many dogs still respond to treatment and can achieve meaningful remission. Your oncologist may adjust the protocol to be more aggressive or explore alternative options.

It's important to know that stage alone doesn't determine your dog's fate. Other factors — including lymphoma type, cell type (B vs. T), overall health, and how quickly treatment begins — all play significant roles.

‍

Why the Right Treatment Matters More Than the Stage

Staging gives your oncologist a starting point, but the most critical factor in your dog's outcome is choosing the treatment most likely to work for their specific cancer. Two dogs with the same stage of lymphoma can respond very differently to the same chemotherapy protocol.

This is exactly why precision medicine is changing the game for canine lymphoma treatment. ImpriMed's drug response testing takes a sample of your dog's actual cancer cells and tests them against multiple chemotherapy drugs to predict which ones will be most effective. Instead of a one-size-fits-all approach, your oncologist gets data-driven guidance to build a personalized treatment plan.

Learn how ImpriMed helps oncologists choose the best treatment for your dog's cancer.